Jun 2, 2026 08:41AM
May 27, 2026 06:50AM
May 13, 2026 06:51AM
May 12, 2026 08:05AM
May 1, 2026 09:17AM
Apr 7, 2026 04:31PM
Apr 6, 2026 08:38AM Unicycive Therapeutics (UNCY) PT Lowered to $15 at Benchmark
Apr 2, 2026 06:43AM
Apr 1, 2026 06:59AM
Feb 17, 2026 09:15AM
Jan 29, 2026 07:05AM
Dec 30, 2025 06:36AM
Dec 29, 2025 07:05AM
Dec 8, 2025 07:32AM Piper Sandler on Biotechnology: 'What Commercial Names to Own in 2026?'
Dec 1, 2025 01:41PM
Nov 12, 2025 08:36AM
Nov 12, 2025 08:10AM
Nov 3, 2025 09:10AM
Oct 29, 2025 06:49AM
Oct 28, 2025 07:06AM
Oct 15, 2025 08:59AM Important Notice to Long-Term Shareholders of Unicycive Therapeutics, Inc. (UNCY): Grabar Law Office Investigates Claims on Your Behalf
Sep 15, 2025 08:57AM
Aug 18, 2025 07:05AM
Aug 14, 2025 04:11PM
Jul 24, 2025 08:02AM
Jul 8, 2025 08:31AM
Jul 1, 2025 09:34AM
Jun 30, 2025 07:05AM Unicycive Therapeutics (UNCY) Announces Receipt of CRL for Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Jun 30, 2025 07:01AM
Jun 17, 2025 07:01AM
Jun 11, 2025 06:38AM
Jun 10, 2025 06:02AM
Jun 4, 2025 06:19AM
May 21, 2025 08:48AM
May 14, 2025 04:59PM Unicycive Therapeutics, Inc. (UNCY) Misses Q1 EPS by 51c
Apr 11, 2025 06:38AM
Apr 10, 2025 09:14AM
Apr 1, 2025 06:46AM
Feb 20, 2025 07:02AM
Jan 28, 2025 07:02AM
Jan 7, 2025 07:01AM
Nov 13, 2024 05:05PM Unicycive Therapeutics, Inc. (UNCY) Tops Q3 EPS by 10c
Nov 12, 2024 07:52AM
Nov 11, 2024 07:01AM
Oct 14, 2024 07:04AM
Oct 10, 2024 06:58AM
Oct 9, 2024 07:04AM
Sep 7, 2024 08:00PM
Sep 6, 2024 06:52AM Benchmark Reiterates Speculative Buy Rating on Unicycive Therapeutics (UNCY)
Sep 4, 2024 07:27AM

396,364 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All